New stock news | Sunwoda Electronic (300207.SZ) Hong Kong IPO prospectus invalidated
Xinwanda Electronics Co., Ltd. (referred to as "Xinwanda", 300207.SZ) submitted the Hong Kong IPO prospectus on July 30, 2025, which expired after 6 months on January 30, 2026. Goldman Sachs and Citic Securities were its joint sponsors at the time of submission.
Sunwoda Electronic Co., Ltd. (referred to as Sunwoda Electronic, 300207.SZ) submitted its Hong Kong IPO prospectus on July 30, 2025, which expired after 6 months on January 30, 2026. Goldman Sachs and CITIC SEC were its joint sponsors at the time of submission.
The prospectus shows that Sunwoda Electronic is a global lithium battery technology company dedicated to providing green and efficient new energy integrated solutions. The company is mainly engaged in the research and development, design, manufacturing, and sales of lithium batteries, covering a rich product matrix including consumer batteries, power batteries, and energy storage systems. It provides global customers with comprehensive solutions from cell, module, system, battery testing, to recycling.
Related Articles

New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?
New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


